BCI
ABBV icon

Brinker Capital Investments’s AbbVie ABBV Stock Holding History

Brinker Capital Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.1M Sell
138,202
-26,780
-16% -$5.94M 0.26% 68
2025
Q4 		$37.7M Buy
164,982
+4,544
+3% +$1.04M 0.28% 57
2025
Q3 		$37.1M Sell
160,438
-2,413
-1% -$491K 0.29% 54
2025
Q2 		$30.2M Buy
162,851
+16,520
+11% +$3.07M 0.26% 73
2025
Q1 		$30.7M Buy
146,331
+3,448
+2% +$670K 0.3% 56
2024
Q4 		$25.4M Buy
142,883
+4,961
+4% +$912K 0.25% 69
2024
Q3 		$27.2M Buy
137,922
+2,021
+1% +$377K 0.27% 64
2024
Q2 		$23.3M Buy
135,901
+55,072
+68% +$9.12M 0.25% 76
2024
Q1 		$14.7M Sell
80,829
-45,462
-36% -$7.84M 0.16% 133
2023
Q4 		$20.4M Sell
126,291
-11,453
-8% -$1.67M 0.24% 87
2023
Q3 		$20.5M Buy
137,744
+20,457
+17% +$3M 0.25% 83
2023
Q2 		$15.8M Buy
117,287
+936
+0.8% +$137K 0.17% 118
2023
Q1 		$18.1M Buy
116,351
+34,225
+42% +$5.23M 0.22% 89
2022
Q4 		$13.3M Sell
82,126
-3,443
-4% -$528K 0.26% 91
2022
Q3 		$11.5M Sell
85,569
-7,077
-8% -$1.02M 0.24% 93
2022
Q2 		$14.2M Sell
92,646
-15,269
-14% -$2.33M 0.27% 83
2022
Q1 		$17.5M Sell
107,915
-11,228
-9% -$1.63M 0.27% 75
2021
Q4 		$16.1M Buy
119,143
+33,316
+39% +$3.94M 0.23% 87
2021
Q3 		$9.63M Sell
85,827
-255
-0.3% -$29.1K 0.15% 133
2021
Q2 		$9.7M Buy
86,082
+15,549
+22% +$1.75M 0.13% 168
2021
Q1 		$7.63M Buy
70,533
+17,626
+33% +$1.89M 0.11% 186
2020
Q4 		$5.67M Sell
52,907
-18,126
-26% -$1.74M 0.09% 268
2020
Q3 		$6.22M Buy
71,033
+60,961
+605% +$5.74M 0.11% 208
2020
Q2 		$989K Sell
10,072
-1,197
-11% -$105K 0.04% 213
2020
Q1 		$859K Sell
11,269
-9,270
-45% -$790K 0.04% 212
2019
Q4 		$1.82M Sell
20,539
-737
-3% -$61.2K 0.06% 184
2019
Q3 		$1.61M Buy
21,276
+873
+4% +$59.9K 0.06% 193
2019
Q2 		$1.48M Sell
20,403
-3,189
-14% -$251K 0.05% 226
2019
Q1 		$1.9M Buy
23,592
+2,311
+11% +$189K 0.06% 194
2018
Q4 		$1.96M Sell
21,281
-186
-0.9% -$16.4K 0.07% 185
2018
Q3 		$2.03M Buy
21,467
+2,378
+12% +$226K 0.06% 176
2018
Q2 		$1.77M Buy
19,089
+2,008
+12% +$196K 0.06% 194
2018
Q1 		$1.62M Buy
17,081
+49
+0.3% +$5.38K 0.05% 193
2017
Q4 		$1.65M Sell
17,032
-5
-0% -$471 0.05% 190
2017
Q3 		$1.51M Buy
17,037
+698
+4% +$53.1K 0.05% 175
2017
Q2 		$1.19M Buy
16,339
+347
+2% +$23.3K 0.05% 193
2017
Q1 		$1.04M Sell
15,992
-230
-1% -$14.5K 0.04% 193
2016
Q4 		$1.02M Sell
16,222
-257
-2% -$15.7K 0.04% 188
2016
Q3 		$1.04M Buy
16,479
+317
+2% +$20.5K 0.04% 179
2016
Q2 		$1M Buy
16,162
+7,703
+91% +$469K 0.04% 181
2016
Q1 		$483K Sell
8,459
-90
-1% -$5.02K 0.02% 214
2015
Q4 		$506K Buy
8,549
+8,540
+94,889% +$492K 0.02% 229
2015
Q3 		$0 Buy
+9
New +$586 ﹤0.01% 451
2014
Q1 		– Sell
-100
Closed -$5K – 388
2013
Q4 		$5K Buy
+100
New +$4.92K ﹤0.01% 349

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Brinker Capital Investments's ABBV Position: Q1 2026 in Review

Brinker Capital Investments reduced its AbbVie (ABBV) stake by 16% in Q1 2026, selling an estimated $5.94M and leaving 138,202 shares worth $30.1M. The position accounts for 0.26% of the portfolio, ranked #68.

Brinker Capital Investments first reported a position in ABBV in Q4 2013 and has held it in 44 quarters since. The position peaked at $37.7M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Brinker Capital Investments held 138,202 shares of AbbVie worth $30.1M as of Q1 2026.
  • Brinker Capital Investments sold 26,780 AbbVie shares in Q1 2026, an estimated $5.94M.
  • AbbVie made up 0.26% of Brinker Capital Investments's portfolio in Q1 2026, its #68 holding.
  • Brinker Capital Investments first reported a position in AbbVie in Q4 2013 and has held it in 44 quarters since.
  • Brinker Capital Investments's AbbVie position peaked at $37.7M in Q4 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.